Pharmaceutical industry – Page 44
-
OpinionEngineering serendipity
It takes more than random stumbling to find new reactions, says Derek Lowe
-
Business
Generics triumph in anti-inflammatory patent battle
Pfizer settles deals to allow copycat celecoxib
-
Business$25bn-plus trade sharpens pharma giants’ focus
Novartis’ asset swaps with GSK and Eli Lilly are the latest steps in an ongoing streamlining process
-
Business
GSK corruption investigation widens
BBC investigation airs allegations of misconduct in Poland
-
BusinessMissing safety risk emails draw $9bn Actos fine
Judge finds absence of Takeda documentation in bladder cancer case ‘disturbing’
-
BusinessSun set on Ranbaxy rescue
Acquiring beleaguered firm will create India’s biggest pharmaceutical company
-
Business
GSK investigates bribery claims in the Middle East
Leaked emails claim GlaxoSmithKline bribed Iraqi doctors and healthcare officials
-
Business
Contamination troubles strike GSK
GlaxoSmithKline is warned over contamination at an Ireland plant, and has recalled Alli from US retailers over tampering concerns.
-
Business
Lilly wins cancer drug patent dispute
Alimta patent will last until 2022 after US court rules in Lilly’s favour
-
Business
Pharma giants plan new public–private collaborations
AstraZeneca and GSK will partner with UK academics to work on early drug discovery
-
Business
Baxter aims to divide and conquer
Firm will split off its biopharmaceuticals business from medical products
-
OpinionKnown unknowns
New molecules with unpredictable biological activity deserve sensible amounts of respect, says Derek Lowe
-
Business
AstraZeneca boosts open innovation efforts
Web portal will make collaborative drug discovery easier
-
Business
$1.2bn J&J deceptive marketing fine overturned
Supreme court reverses decision to fine firm over Risperdal promotion
-
Business
US focuses pharma supply chain scrutiny
Import pre-authorisation for trusted firms frees up resources to tackle purity problems
-
Business
UK to fast-track access to critical medicines
Patients could receive medicines before formal approval in exchange for monitoring data
-
Business
Bristol-Myers Squibb to close Irish plant
130 jobs to go at manufacturing site in Cruiserath
-
BusinessMegamerger brings Actavis into R&D race
$25bn Forest Labs takeover will see generics giant take on patented products